Cargando…
Chinese SLE Treatment and Research Group Registry (CSTAR) XIV: the subjective well-being of patients with systemic lupus erythematosus
BACKGROUND: Systemic lupus erythematosus (SLE) can significantly influence patients’ quality of life and subjective well-being (SWB), but the relationships between clinical characteristics, SWB, and related psychological factors have been little studied. OBJECTIVE: To measure SWB in patients with SL...
Autores principales: | Shi, Yue, Bi, Dandan, Wang, Yanhong, Li, Ruofan, Wu, Lijun, Zhao, Cheng, Wu, Zhenbiao, Duan, Xinwang, Xu, Jian, Zhan, Feng, Yang, Min, Liu, Shengyun, Li, Qin, Zhang, Shuo, Liu, Lingshan, Zhao, Jiuliang, Tian, Xinping, Li, Xinying, Wang, Qian, Zeng, Xiaofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531862/ https://www.ncbi.nlm.nih.gov/pubmed/36203761 http://dx.doi.org/10.3389/fmed.2022.984183 |
Ejemplares similares
-
Sex differences in systemic lupus erythematosus (SLE): an inception cohort of the Chinese SLE Treatment and Research Group (CSTAR) registry XVII
por: Gui, Yinli, et al.
Publicado: (2022) -
Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus
por: Xiang, Yirong, et al.
Publicado: (2021) -
Chinese SLE Treatment and Research Group (CSTAR) Registry 2009–2019: Major Clinical Characteristics of Chinese Patients with Systemic Lupus Erythematosus
por: Li, Mengtao, et al.
Publicado: (2021) -
Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII
por: Cheng, Cheng, et al.
Publicado: (2023) -
Sirolimus versus tacrolimus for systemic lupus erythematosus treatment: results from a real-world CSTAR cohort study
por: Jiang, Nan, et al.
Publicado: (2022)